Khurram M Siddiqui1, Jonathan I Izawa2. 1. Departments of Surgery, Oncology and Pathology, Divisions of Urology and Surgical Oncology, Schulich School of Medicine & Dentistry, London Health Sciences Centre-Victoria Hospital, Western University, 800 Commissioners Road East, Room E2-649, London, ON, N6A 5W9, Canada. 2. Departments of Surgery, Oncology and Pathology, Divisions of Urology and Surgical Oncology, Schulich School of Medicine & Dentistry, London Health Sciences Centre-Victoria Hospital, Western University, 800 Commissioners Road East, Room E2-649, London, ON, N6A 5W9, Canada. jonathan.izawa@lhsc.on.ca.
Abstract
PURPOSE: Ileal conduit (IC) is the most frequent urinary diversion (UD) performed after radical cystectomy (RC). We reviewed the literature to investigate the factors influencing the choice of this diversion and its complications. METHODS: A literature search (PubMed) was performed for all English language publications on UDs performed for treatment of bladder cancer from 1950 to 2015. The literature review was focused on studies reporting outcome of IC and its comparison with other types of UDs. RESULTS: IC is the most common UD performed in elderly patients undergoing RC for bladder cancer. Long-term studies looking at the change in renal function after UD report a universal decline in the glomerular filtration rate; however, this decline in renal function is the least for IC. There is a significant morbidity of RC (20-56 %), which can be attributed to patient factors, surgical technique and hospital volume. Modern concepts of bowel preparation, postoperative nutrition, early enteral feeding and involvement of stoma therapists have helped improve the outcomes. The quality of life is preserved, and in many including elderly, it may be improved with IC UD. CONCLUSIONS: IC is the most commonly performed UD following radical cystectomy. It is associated with acceptable morbidity and has the lowest reoperation rates as compared to continent diversion. It is also the procedure of choice for most patients' elderly patients as well as patients with limited dexterity, poor motivation, anatomical restrictions and poor renal function. Studies measuring HRQOL report excellent patient acceptability, especially in the elderly population.
PURPOSE: Ileal conduit (IC) is the most frequent urinary diversion (UD) performed after radical cystectomy (RC). We reviewed the literature to investigate the factors influencing the choice of this diversion and its complications. METHODS: A literature search (PubMed) was performed for all English language publications on UDs performed for treatment of bladder cancer from 1950 to 2015. The literature review was focused on studies reporting outcome of IC and its comparison with other types of UDs. RESULTS: IC is the most common UD performed in elderly patients undergoing RC for bladder cancer. Long-term studies looking at the change in renal function after UD report a universal decline in the glomerular filtration rate; however, this decline in renal function is the least for IC. There is a significant morbidity of RC (20-56 %), which can be attributed to patient factors, surgical technique and hospital volume. Modern concepts of bowel preparation, postoperative nutrition, early enteral feeding and involvement of stoma therapists have helped improve the outcomes. The quality of life is preserved, and in many including elderly, it may be improved with IC UD. CONCLUSIONS: IC is the most commonly performed UD following radical cystectomy. It is associated with acceptable morbidity and has the lowest reoperation rates as compared to continent diversion. It is also the procedure of choice for most patients' elderly patients as well as patients with limited dexterity, poor motivation, anatomical restrictions and poor renal function. Studies measuring HRQOL report excellent patient acceptability, especially in the elderly population.
Authors: Niall F Davis; John P Burke; Ted McDermott; Robert Flynn; Rustom P Manecksha; John A Thornhill Journal: Can Urol Assoc J Date: 2015 May-Jun Impact factor: 1.862
Authors: Atiqullah Aziz; Matthias May; Maximilian Burger; Rein-Jüri Palisaar; Quoc-Dien Trinh; Hans-Martin Fritsche; Michael Rink; Felix Chun; Thomas Martini; Christian Bolenz; Roman Mayr; Armin Pycha; Philipp Nuhn; Christian Stief; Vladimir Novotny; Manfred Wirth; Christian Seitz; Joachim Noldus; Christian Gilfrich; Shahrokh F Shariat; Sabine Brookman-May; Patrick J Bastian; Stefan Denzinger; Michael Gierth; Florian Roghmann Journal: Eur Urol Date: 2013-12-27 Impact factor: 20.096
Authors: Jeffrey J Leow; Stephen Reese; Quoc-Dien Trinh; Joaquim Bellmunt; Benjamin I Chung; Adam S Kibel; Steven L Chang Journal: BJU Int Date: 2015-01-26 Impact factor: 5.588
Authors: J Schiffmann; G Gandaglia; A Larcher; M Sun; Z Tian; S F Shariat; M McCormack; L Valiquette; F Montorsi; M Graefen; F Saad; P I Karakiewicz Journal: Eur J Surg Oncol Date: 2014-10-15 Impact factor: 4.424
Authors: S Joniau; J Benijts; M Van Kampen; M De Waele; J Ooms; B Van Cleynenbreugel; H Van Poppel Journal: Eur Urol Date: 2005-01-20 Impact factor: 20.096
Authors: Hector Garde; Marco Ciappara; Isabel Galante; Manuel Fuentes Ferrer; Angel Gómez; Jesus Blazquez; Jesus Moreno Journal: Urol Int Date: 2015-02-11 Impact factor: 2.089
Authors: Luke T Lavallée; David Schramm; Kelsey Witiuk; Ranjeeta Mallick; Dean Fergusson; Christopher Morash; Ilias Cagiannos; Rodney H Breau Journal: PLoS One Date: 2014-10-31 Impact factor: 3.240
Authors: Andrea Fuschi; Yazan Al Salhi; Manfredi Bruno Sequi; Gennaro Velotti; Alessia Martoccia; Paolo Pietro Suraci; Silvio Scalzo; Anastasios Asimakopoulos; Giorgio Bozzini; Alessandro Zucchi; Cosimo De Nunzio; Antonio Carbone; Antonio Luigi Pastore Journal: J Clin Med Date: 2021-12-27 Impact factor: 4.241